Investors in Investor

Dexia

Corporate VC

Leading historically in the fields of public finance sector and retail banking, Dexia is a European banking group managed to an orderly resolution since the end of 2011. Dexia SA, the Group’s parent company, is a limited company under Belgian Law, with its shares listed on Euronext Brussels and Paris as well as the Luxembourg Stock Exchange. Since the end of 2012, a capital increase has been subscribed by the Belgian and French States, those two States being the Group’s main shareholders.

France Pre-Seed / Seed, Series A/B
€100k-€1.5M

BOLD (Business Opportunities for L'Oréal Development) is a venture fund of L'Oréal. BOLD is the strategic venture capital fund of L'Oréal. We invest in brands, technology, and biotech & green science that are redefining the frontier of beauty. We partner with the next generation of beauty innovators and disruptors to create the beauty that moves the world.

France Pre-Seed / Seed, Series A/B
€100k-€1.5M

Eviny Ventures

Corporate VC

Eviny Ventures is the venture fund of the Eviny Group, which invests in start-up and growth companies that think new and have the potential to play a key role in the renewable society of the future. Eviny Ventures is an active early stage investor in companies with great potential that help accelerate the transformation towards a sustainable future. We are hands-on with founders, from seed to venture to growth. As you drive your business forward, we’ll help you prepare for the biggest possible outcomes by leveraging our solid expertise and network from 100+ years in the renewable energy industry.

Norway Pre-Seed / Seed, Series A/B, Series C & Beyond
€100k-€1.5M

Corporate venture capital fund of Air Liquide Groupe.Air Liquide, a global leader in gases, technologies, and services for Industry and Health, offers essential small molecules like oxygen, nitrogen, and hydrogen. With a strong focus on innovation and sustainability.

France Pre-Seed / Seed, Series A/B
€100k-€1.5M

DocCheck Guano

Corporate VC

Birds of a feather flock together? Not our style! We promote healthcare startups who believe in their vision and want to be a success at it. DocCheck Guano is a hatchery for precocial birds aiming to land in the market. We provide the ideal fertiliser for startups: capital, know-how, market access and network. Oh, and our focus is on seed funding.

Germany Pre-Seed / Seed, Series A/B
€100k-€1.5M

Aliaxis Next

Corporate VC

Aliaxis Next is an impact business builder division of Aliaxis. We are Aliaxis Next, a team of business builders who identify, engage, and accelerate water tech companies and entrepreneurs through our four business units: Sustainable Water Management, Access to Water, Resilient Water Infrastructure, and Water for Food. As a world leader in fluid management solutions, we are investing at pace in the technologies we will need to solve the immense water challenges of the future. And we’re laying the foundations for our continued growth beyond 2025.

Belgium Pre-Seed / Seed, Series A/B, Series C & Beyond
0-€100k

Crescent Ventures

Corporate VC

Crescent Ventures develops and delivers dependable, secure, and environmentally friendly Internet of Things solutions for smart buildings, smart cities, industry 4.0, and smart energy applications around the world. They enable and accelerate the transition to a safer, more sustainable, and more comfortable living environment, allowing businesses to thrive. The group is organized along 3 business units: Crescent IoT Solutions, Crescent Lighting and Crescent Ventures.

Belgium Pre-Seed / Seed, Series A/B
€100k-€1.5M

Siena Secondary Fund provides liquidity for early investors, founders and employees of high growth startups from the Nordics & CEE region. We target companies which are usually post series A, have solid business model and are still in high growth phase.

Estonia Series A/B, Series C & Beyond
€1.5M-€3M

ACE & Company (ACE) is a multi-stage private equity and venture capital group built on a unique combination of expertise, experience, and knowledge of its founders and team. The group has $1.7bn total assets across Secondaries, Buyout, Ventures, and Investment Solutions. A Multi-Stage Specialist Across Private Equity. ACE Ventures is a team of operators, engineers, and investors deploying capital and expertise to empower and support outliers.

Switzerland Pre-Seed / Seed, Series A/B
€1.5M-€3M

Carbon Removal Partners is a Zurich-based VC with a pure focus on the growing Carbon Removal industry. Carbon Removal Partners invests into technologies to withdraw carbon from the atmosphere in a permanent manner, as well as into companies along the Carbon Removal value chain. It is our goal to collaborate with the most ambitious entrepreneurs in the industry to make the need of reversing humanity's carbon streams become a reality. Carbon Removal Partners takes decisions with regards to its deepest conviction that carbon removal will take on an indispensable role among other carbon reduction strategies. Well aware of today's challenges we seek to enable systemic change.

Switzerland Pre-Seed / Seed, Series A/B
€1.5M-€3M

14Peaks is an early-stage investor in B2B SaaS companies in the fintech and future of work verticals, with a geographic focus on Europe and the US. 14Peaks initially partners with founders from pre-seed to Series A and provides on-going support throughout their growth journey via capital, operational involvement, network access and strategic advice. Partner with us:

Switzerland Pre-Seed / Seed
€1.5M-€3M

Yaya Capital

VC Firm

Yaya Capital is a healthcare investment firm that operates in a multi-stage strategy aimed at empowering top entrepreneurs by providing strategic support, specialized knowledge and connectivity through its robust network. Far beyond money, we put our experience, knowledge and execution capabilities to support companies that will improve the life and health of people around the world. With presence in Brazil, Switzerland, US (Palo Alto and New York) and Portugal, we are a global team of investors, entrepreneurs, scientists, doctors and innovation experts with proven experience in the healthcare industry.

Switzerland Series A/B
€1.5M-€3M
Showing 37-48 of 54 items